Evolus, Inc.

24
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US30052C1071
USD
6.81
0.29 (4.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Evolus, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-49.00
-61.00
-74.00
-46.00
-162.00
-105.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-6.00
-5.00
-34.00
-11.00
35.00
-20.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-17.00
-34.00
-84.00
-33.00
-57.00
-93.00
Cash Flow from Investing Activities
-4.00
-1.00
-2.00
4.00
12.00
-23.00
Cash Flow from Financing Activities
47.00
44.00
-4.00
73.00
38.00
133.00
Net Cash Inflow / Outflow
24.00
8.00
-92.00
43.00
-7.00
16.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Evolus, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-49.756
-82.317
33.00
39.56%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-6.604
-14.057
8.00
53.02%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-17.999
-76.445
59.00
76.45%
Cash Flow from Investing Activities
-4.823
49.468
-53.00
-109.75%
Cash Flow from Financing Activities
47.414
0.542
47.00
8647.97%
Net Cash Inflow / Outflow
24.114
-26.551
50.00
190.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.478
-0.116
0.00
-312.07%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 47.07% vs 59.95% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-18.00
-34.01
47.07%